NCT02557594View on ClinicalTrials.gov

Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 6, 2015

Primary Completion Date

November 17, 2015

Study Completion Date

March 8, 2016

Conditions
Healthy
Interventions
DRUG

Viread 300mg

single dose administration after 10hr fasting

DRUG

DA-2802 319mg

single dose administration after 10hr fasting

Trial Locations (1)

110-744

Clinical Trial Center, Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02557594 - Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter